Petersham, Australia

Nicholas King

This inventor holds 2 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Cour Pharmaceuticals Development Company, Inc., Oncour Pharma, Inc.. Active years: 2019-2021.

USPTO Granted Patents = 2 

% Patents Active = 100.0



Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Nicholas King

Introduction

Nicholas King is an accomplished inventor based in Petersham, Australia. He has made significant strides in the field of immunology, particularly through his innovative patents that focus on immune-modulating particles. With a total of 2 patents, his work has the potential to impact the treatment of inflammatory diseases.

Latest Patents

One of Nicholas King's latest patents is centered around modified immune-modulating particles. This invention relates to methods aimed at reducing the duration or severity of an inflammatory immune response. The method involves administering poly (lactic acid) (PLA) particles, poly (glycolic acid) (PGA) particles, poly (lactic-co-glycolic acid) (PLGA) particles, or combinations thereof. Notably, these particles are modified to contain one or more carboxyl groups on their surface, and they do not comprise therapeutically active ingredients. Another significant patent involves the surprising finding that carboxylated particles, such as carboxylated polystyrene, PLGA, or diamond particles, can ameliorate inflammatory immune responses when administered to subjects. This invention also describes methods for treating inflammatory diseases using these carboxylated particles.

Career Highlights

Throughout his career, Nicholas King has worked with notable companies in the pharmaceutical sector, including Cour Pharmaceuticals Development Company, Inc. and Oncour Pharma, Inc. His contributions to these organizations have been instrumental in advancing research and development in immunology.

Collaborations

Nicholas has collaborated with esteemed colleagues such as Daniel R. Getts and Rachael Terry. These partnerships have fostered a collaborative environment that enhances innovation and research in the field.

Conclusion

Nicholas King's innovative work in the development of immune-modulating particles showcases his commitment to advancing medical science. His patents hold promise for improving treatments for inflammatory diseases, marking him as a significant figure in the field of immunology.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…